BENCY SONY: Open Payments
NPI 1932665304 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 53 payments from 18 companies in 2025. Trend: 2023 $46 · 2024 $437 · 2025 $1,079
Food & beverage: $1,079
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $348 |
| PFIZER INC. | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Novo Nordisk Inc | 4 | $90 |
| Exact Sciences Corporation | 3 | $51 |
| ABBVIE INC. | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $46 |
| SANOFI PASTEUR INC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
Products named: FARXIGA, AIRSUPRA, REXULTI, PREVNAR 20, Ozempic, UBRELVY, EVENITY, BREZTRI.
Industry payments across OK — which companies pay providers there.
